Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Chamath Palihapitiya has been labeled the King of SPACs and it could come with good reason.
What Happened: Palihapitiya has launched six SPACs on his quest to bring SPACs with tickers IPOA to IPOZ to market. Three of the SPACs have completed deals, one has a pending merger and two are still searching for targets.
Palihapitiya has also been involved with six SPACs as a member of the private investment in public equity, commonly referred to as the PIPE.
The investor tweeted last Friday to “trust the process” after a short report from Hindenburg Research attacked his recently completed SPAC deal Clover Health Investments (NASDAQ:CLOV). The tweet shows that all 12 deals he has been a part of have performed well.
Related Link: 5 Things You Might Not Know About Chamath Palihapitiya
The Palihapitiya SPACs: A look at the SPACs.
The PIPE Deals: Along with his own SPACs, Palihapitiya has funded six SPAC deals as a member of the PIPE.
Disclosure: The author is long shares SPCE, IPOD, SPRQ.
Strong Performance And Demand: The 12 SPAC deals that Palihapitiya has been involved in have produced an average 47% return for shareholders in 2021. The average lifetime gain for the 12 SPAC deals involving the SPAC King is 137%.
A Twitter poll tracking how many of the 12 SPACs are currently and were at some point owned by responders showed strong interest in Palihapitiya SPACs.
Okay new question for my #spacsquad on this Friday night. Of the 12 Chamath spacs listed below, how many do you currently own and how many of them have you owned at some point. For me it is 4/6. @SpacGuru @SpacTiger @BillSPACman @Mindwalletbody @stocktalkweekly @SPACtrack https://t.co/Xv7KNbP8U5
— Chris Katje (@chriskatje) February 5, 2021
Posted In: ACTC CLOV DM INSU IPOD IPOE IPOF MP OPEN SPCE SPRQ TSIA